Mechanisms of action of hydrogen sulfide in relaxation of mouse distal colonic smooth muscle

European Journal of Pharmacology

Volumn 628, Issue 1-3, 2010, Pages 179-186

  Dhaese, Ingeborg ^a   Van Colen, Inge ^a   Lefebvre, Romain A ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Calcium; Cystathionine synthase; Cystathionine lyase; Hydrogen sulfide; Mouse distal colon; Potassium channel

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; 4 AMINOPYRIDINE; 9 (TETRAHYDRO 2 FURYL)ADENINE; APAMIN; BARIUM CHLORIDE; CALCIUM ION; CALYCULIN A; CAPSAZEPINE; CHARYBDOTOXIN; GLIBENCLAMIDE; HYDROGEN SULFIDE; N(G) NITROARGININE METHYL ESTER; OMEGA CONOTOXIN; POTASSIUM CHANNEL; PROSTAGLANDIN F2 ALPHA; RECEPTOR BLOCKING AGENT; RHO KINASE; SODIUM HYDROGEN SULFIDE; SULFUR DERIVATIVE; TETRODOTOXIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COLON; CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVATION; ENZYME INHIBITION; INTESTINE MUSCLE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE RELAXATION; SMOOTH MUSCLE TONE;

ANIMALS; CALCIUM; COLON; CYTOSOL; ENZYME INHIBITORS; HYDROGEN SULFIDE; MALE; MICE; MUSCLE CONTRACTION; MUSCLE RELAXATION; MUSCLE, SMOOTH; NERVOUS SYSTEM; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS;

EID: 73649099819     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.11.024     Document Type: Article

References (41)

1. Abe K., and Kimura H. The possible role of hydrogen sulfide as an endogenous neuromodulator. J. Neurosci. 16 3 (1996) 1066-1071
2. Bayguinov O., Hagen B., Bonev A.D., Nelson M.T., and Sanders K.M. Intracellular calcium events activated by ATP in murine colonic myocytes. Am. J. Physiol., Cell Physiol. 279 (2000) C126-C135
3. Cheng Y., Ndisang J.F., Tang G., Cao K., and Wang R. Hydrogen sulfide-induced relaxation of resistance mesenteric artery beds of rats. Am. J. Physiol. Heart Circ. Physiol. 287 (2004) H2316-H2323
4. 2+ desensitization. Br. J. Pharmacol. 144 (2005) 588-594
5. De Backer O., and Lefebvre R.A. Mechanisms of relaxation by carbon monoxide-releasing molecule-2 in murine gastric fundus and jejunum. Eur. J. Pharmacol. 572 (2007) 197-206
6. Delaey C., and Van de Voorde J. Heterogeneity of the inhibitory influence of sulfonylureas on prostanoid-induced smooth muscle contraction. Eur. J. Pharmacol. 325 (1997) 41-46
7. Dhaese I., and Lefebvre R.A. Myosin light chain phosphatase activation is involved in the hydrogen sulfide-induced relaxation in mouse gastric fundus. Eur. J. Pharmacol. 606 1-3 (2009) 180-186
8. Ca channels in NANC relaxation of mouse distal colon. Eur. J. Pharmacol. 589 (2008) 251-259
9. Gallego D., Clavé P., Donovan J., Rahmati R., Grundy D., Jiménez M., and Beyak M.J. The gaseous mediator, hydrogen sulphide, inhibits in vitro motor patterns in the human, rat and mouse colon and jejunum. Neurogastroenterol. Motil. 20 (2008) 1306-1316
10. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260 6 (1985) 3440-3450
11. 2+ sensitivity in vascular smooth muscle. J. Smooth Muscle Res. 40 6 (2004) 219-236
12. 3-adrenoceptor-mediated, cyclic AMP-independent relaxations of guinea pig gastrointestinal smooth muscles. Naunyn-Schmiedeberg's Arch. Pharmacol. 367 (2003) 193-203
13. Hosoki R., Matsuki N., and Kimura H. The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem. Biophys. Res. Commun. 237 (1997) 527-531
14. Jaggar J.H., Porter V.A., Lederer W.J., and Nelson M.T. Calcium sparks in smooth muscle. Am. J. Physiol., Cell physiol. 278 (2000) C235-C256
15. Kelm M., and Schrader J. Control of coronary vascular tone by nitric oxide. Circ. Res. 66 (1990) 1561-1575
16. Kim M., Han I.S., Koh S.D., and Perrino B.A. Roles of CaM kinase II and phospholamban in SNP-induced relaxation of murine gastric fundus smooth muscles. Am. J. Physiol., Cell Physiol. 291 (2006) C337-C347
17. Kubo S., Doe I., Kurokawa Y., and Kawabata A. Hydrogen sulfide causes relaxation in mouse bronchial smooth muscle. J. Pharm. Sci. 104 (2007) 392-396
18. Kubo S., Doe I., Kurokawa Y., Nishikawa H., and Kawabata A. Direct inhibition of endothelial nitric oxide synthase by hydrogen sulfide: contribution to dual modulation of vascular tension. Toxicology 232 (2007) 138-146
19. Kwon S.-C., Ozaki H., and Karaki H. NO donor sodium nitroprusside inhibits excitation-contraction coupling in guinea pig taenia coli. Am. J. Physiol.: Gastrointest. Liver Physiol. 279 (2000) G1235-G1241
20. Levine J., Ellis C.J., Furne J.K., Springfield J., and Levitt M.D. Fecal hydrogen sulphide production in ulcerative colitis. Am. J. Gastroenterol. 93 (1998) 83-87
21. Linden D.R., Sha L., Mazzone A., Stoltz G.J., Bernard C.E., Furne J.K., Levitt M.D., Farrugia G., and Szurszewski J.H. Production of the gaseous signal molecule hydrogen sulfide in mouse tissues. J. Neurochem. 106 (2008) 1577-1585
22. Nakajima H., Goto H., Azuma Y.-T., Fujita A., and Takeuchi T. Functional interactions between the SK2 channel and the nicotinic acetylcholine receptor in enteric neurons of the guinea pig ileum. J. Neurochem. 103 (2007) 2428-2438
23. Olson K.R., Dombkowski R.A., Russell M.J., Doellman M.M., Head S.K., Whitfield N.L., and Madden J.A. Hydrogen sulfide as an oxygen sensor/transducer in vertebrate hypoxic vasocontraction and hypoxic vasodilation. J. Exp. Biol. 209 (2006) 4011-4023
24. 2 receptor agonist cicaprost via a cyclic AMP-independent mechanism. Cardiovasc. Res. 69 (2006) 107-115
25. 2S) stimulates capsaicin-sensitive primary afferent neurons in the rat urinary bladder. Br. J. Pharmacol. 142 (2004) 31-34
26. Porcher C., Horowitz B., Ward S.M., and Sanders K.M. Constitutive and functional expression of cyclooxygenase 2 in the murine proximal colon. Neurogastroenterol. Motil. 16 (2004) 785-799
27. + channels expressed in murine colonic smooth muscle. Am. J. Physiol.: Gastrointest. Liver Physiol. 281 (2001) G964-G973
28. 2+ signal and contraction in rat aorta. Br. J. Pharmacol. 114 (1995) 1731-1737
29. Schicho R., Krueger D., Zeller F., Von Weyhern C.W.H., Frieling T., Kimura H., Ishii I., De Giorgio R., Campi B., and Schemann M. Hydrogen sulfide is a novel prosecretory neuromodulator in the guinea-pig and human colon. Gastroenterology 131 (2006) 1542-1552
30. 2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosine phosphatase. Physiol. Rev. 83 (2003) 1325-1358
31. Stipanuk M.H., and Beck P.W. Characterization of the enzymic capacity for cysteine desulphhydration in liver and kidney of the rat. Biochem. J. 206 (1982) 267-277
32. + channels stably expressed in HEK 293 cells. Br. J. Pharmacol. 129 (2000) 991-999
33. ATP channels by exogenous and endogenous hydrogen sulfide in vascular smooth muscle cells. Mol. Pharmacol. 68 (2005) 1757-1764
34. 2+ sensitivity of light chain phosphorylation within smooth muscle cells. J. Biol. Chem. 269 13 (1994) 9912-9920
35. Teague B., Asiedu S., and Moore P.K. The smooth muscle relaxant effect of hydrogen sulphide in vitro: evidence for a physiological role to control intestinal contractility. Br. J. Pharmacol. 137 (2002) 139-145
36. Van Crombruggen K., and Lefebvre R.A. Nitrergic-purinergic interactions in rat distal colon motility. Neurogastroenterol. Motil. 16 (2004) 81-98
37. Webb G.D., Lim L.H., Oh V.M., Yeo S.B., Cheong Y.P., Ali M.Y., Oakley R.E., Lee C.N., Wong P.S., Caleb M.G., Salto-Tellez M., Bhatia M., Chan E.S.Y., Taylor E.A., and Moore P.K. Contractile and vasorelaxant effects of hydrogen sulfide and its biosynthesis in the human internal mammary artery. J. Pharmacol. Exp. Ther. 324 (2008) 876-882
38. +-ATPase by NO produced from sodium nitrite by ultraviolet light in mouse gastric fundal strip. Gen. Pharmacol. 32 1 (1999) 159-162
39. 2S-induced vasorelaxation and underlying cellular and molecular mechanisms. Am. J. Physiol. Heart Circ. Physiol. 283 (2002) H474-H480
40. ATP channel opener. EMBO J. 20 (2001) 6008-6016
41. Zizzo M.G., Mulé F., and Serio R. Mechanisms underlying the nitric oxide inhibitory effects in mouse ileal longitudinal muscle. Can. J. Physiol. Pharm. 83 (2005) 805-810